Cyrus Biotechnology Funding: $8M Raised, Series A (2017)
Cyrus Biotechnology is based in Seattle. It has raised $8M in total funding. Latest round: Series A.
Cyrus Biotechnology funding overview
Cyrus Biotechnology is based in Seattle. Cyrus Biotechnology has raised $8M in total disclosed funding. That places its disclosed total in the $1M–$25M range. Its most recent disclosed round is a Series A announced in July 2017. The round record for Cyrus Biotechnology runs through 2017; nothing later has been disclosed. Investors on record include Trinity Ventures, OrbiMed Advisors, SpringRock Ventures, W Fund. 4 distinct backers are named across the disclosed rounds.
Cyrus Biotechnology at a glance
Total raised
$8M
Latest round
Series A
Latest round date
July 2017
Headquarters
Seattle
Notable investors
Trinity Ventures, OrbiMed Advisors, SpringRock Ventures, W Fund
Frequently asked about Cyrus Biotechnology funding
How much has Cyrus Biotechnology raised?
Cyrus Biotechnology has raised $8M in total disclosed funding across the rounds on record.
Who has invested in Cyrus Biotechnology?
Trinity Ventures, OrbiMed Advisors, SpringRock Ventures, W Fund are named among the investors backing Cyrus Biotechnology.
What was the latest Cyrus Biotechnology funding round?
The most recent disclosed round is a Series A, announced in July 2017.
Where is Cyrus Biotechnology based?
Cyrus Biotechnology is based in Seattle.
When did Cyrus Biotechnology last raise?
The last disclosed Cyrus Biotechnology round closed in July 2017 at Series A.
Round data for Cyrus Biotechnology is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the companies in Seattle and backer lists below.
